Cargando…

Efficacy and Safety of Empagliflozin Continuation in Patients with Type 2 Diabetes Hospitalised for Acute Decompensated Heart Failure

There is little evidence on the use of sodium−glucose cotransporter 2 inhibitors in hospitalised patients. This work aims to analyse the glycaemic and clinical efficacy and safety of empagliflozin continuation in patients with type 2 diabetes hospitalised for acute decompensated heart failure. This...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pérez-Belmonte, Luis M., Ricci, Michele, Sanz-Cánovas, Jaime, Millán-Gómez, Mercedes, Osuna-Sánchez, Julio, Ruiz-Moreno, M. Isabel, Bernal-López, M. Rosa, López-Carmona, María D., Jiménez-Navarro, Manuel, Gómez-Doblas, Juan J., Lara, José P., Gómez-Huelgas, Ricardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396978/ https://www.ncbi.nlm.nih.gov/pubmed/34441835 http://dx.doi.org/10.3390/jcm10163540

Ejemplares similares

De-Intensification of Antidiabetic Treatment Using Canagliflozin in Patients with Heart Failure and Type 2 Diabetes: Cana-Switch-HF Study
por: Pérez-Belmonte, Luis M., et al.
Publicado: (2021)

Use of Linagliptin for the Management of Medicine Department Inpatients with Type 2 Diabetes in Real-World Clinical Practice (Lina-Real-World Study)
por: Pérez-Belmonte, Luis M., et al.
Publicado: (2018)

Differences between Clinical Protocols for the Treatment of Coronavirus Disease 2019 (COVID-19) in Andalusia, Spain
por: Pérez-Belmonte, Luis M., et al.
Publicado: (2020)

Statins and Peripheral Arterial Disease: A Narrative Review
por: Jansen-Chaparro, Sergio, et al.
Publicado: (2021)

Statin Therapy in Very Old Patients: Lights and Shadows
por: Cobos-Palacios, Lidia, et al.
Publicado: (2021)

Management of Type 2 Diabetes Mellitus in Elderly Patients with Frailty and/or Sarcopenia
por: Sanz-Cánovas, Jaime, et al.
Publicado: (2022)

Remission of type 2 diabetes: A critical appraisal
por: Ricci, Michele, et al.
Publicado: (2023)

Familial Aortic Coarctation: A Rare Cause of Refractory Hypertension in the Elderly: A Case Report
por: Lara-Rojas, Carmen M., et al.
Publicado: (2015)

Lifestyle Modification Program on a Metabolically Healthy Elderly Population with Overweight/Obesity, Young-Old vs. Old-Old. CONSEQUENCES of COVID-19 Lockdown in This Program
por: Cobos-Palacios, Lidia, et al.
Publicado: (2021)

Corticosteroid therapy in patients with heart failure hospitalized for COVID-19: a multicenter retrospective study
por: Pérez-Belmonte, Luis M., et al.
Publicado: (2021)

Metabolically healthy obesity: Inflammatory biomarkers and adipokines in elderly population
por: Cobos-Palacios, Lidia, et al.
Publicado: (2022)

Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice
por: Pérez-Belmonte, Luis M., et al.
Publicado: (2022)

Relationship between quadriceps femoris muscle architecture and muscle strength and physical function in older adults with heart failure with preserved ejection fraction
por: Fuentes-Abolafio, Iván J., et al.
Publicado: (2022)

Obesity, Diabetes, and Cardiovascular Risk Burden in Systemic Lupus Erythematosus: Current Approaches and Knowledge Gaps—A Rapid Scoping Review
por: Hernández-Negrín, Halbert, et al.
Publicado: (2022)

Síndrome de COVID-19 persistente. Una revisión narrativa
por: López-Sampalo, A., et al.
Publicado: (2022)

Persistent COVID-19 syndrome. A narrative review()
por: López-Sampalo, A., et al.
Publicado: (2022)

Biomarkers and the quadriceps femoris muscle architecture assessed by ultrasound in older adults with heart failure with preserved ejection fraction: a cross-sectional study
por: Fuentes-Abolafio, Iván José, et al.
Publicado: (2022)

Trends in Diabetes-Related Potentially Preventable Hospitalizations in Adult Population in Spain, 1997–2015: A Nation-Wide Population-Based Study
por: Gómez-Huelgas, Ricardo, et al.
Publicado: (2019)

COVID-19 in Older Patients: Assessment of Post-COVID-19 Sarcopenia
por: López-Sampalo, Almudena, et al.
Publicado: (2023)

Alterations of specific biomarkers of metabolic pathways in vascular tree from patients with Type 2 diabetes
por: Rosa, Bernal-Lopez M, et al.
Publicado: (2012)

Utility of Liver Function Tests and Fatty Liver Index to Categorize Metabolic Phenotypes in a Mediterranean Population
por: Narankiewicz, Dariusz, et al.
Publicado: (2020)

CD36 overexpression: a possible etiopathogenic mechanism of atherosclerosis in patients with prediabetes and diabetes
por: Lopez-Carmona, M. D., et al.
Publicado: (2017)

Empagliflozin reduces markers of acute kidney injury in patients with acute decompensated heart failure
por: Thiele, Kirsten, et al.
Publicado: (2022)

Functional parameters indicative of mild cognitive impairment: a systematic review using instrumented kinematic assessment
por: Fuentes-Abolafio, Iván José, et al.
Publicado: (2020)

Physical functional performance and prognosis in patients with heart failure: a systematic review and meta-analysis
por: Fuentes-Abolafio, Iván José, et al.
Publicado: (2020)

Metabolically Healthy Obesity: Presence of Arterial Stiffness in the Prepubescent Population
por: Ruiz-Moreno, Maria Isabel, et al.
Publicado: (2020)

Clinical characteristics and risk factors for mortality upon admission in patients with heart failure hospitalized due to COVID-19 in Spain()
por: Salinas-Botrán, A., et al.
Publicado: (2022)

Características clínicas y factores de riesgo de mortalidad al ingreso en pacientes con insuficiencia cardíaca hospitalizados por COVID-19 en España
por: Salinas-Botrán, A., et al.
Publicado: (2022)

Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease) after laparoscopic Roux-en-Y gastric bypass for morbid obesity: a case report
por: Garcia-Arnes, Juan, et al.
Publicado: (2012)

Kinematic Parameters That Can Discriminate in Levels of Functionality in the Six-Minute Walk Test in Patients with Heart Failure with a Preserved Ejection Fraction
por: Fuentes-Abolafio, Iván José, et al.
Publicado: (2022)

Metformin-Induced Hepatotoxicity
por: Miralles-Linares, Francisco, et al.
Publicado: (2012)

Estimation of Functional Aerobic Capacity Using the Sit-to-Stand Test in Older Adults with Heart Failure with Preserved Ejection Fraction
por: Fuentes-Abolafio, Iván José, et al.
Publicado: (2022)

“When the virus decompensated the neurosis.” About a case
por: Valverde Barea, M., et al.
Publicado: (2022)

Comparison of Canagliflozin, Dapagliflozin and Empagliflozin Added to Heart Failure Treatment in Decompensated Heart Failure Patients With Type 2 Diabetes Mellitus
por: Nakagaito, Masaki, et al.
Publicado: (2019)

Treating Patients Following Hospitalisation for Acute Decompensated Heart Failure: An Insight into Reducing Early Rehospitalisations
por: Iacovoni, Attilio, et al.
Publicado: (2019)

Complications and Mortality in Hospitalised Patients With Decompensated Cirrhosis of Liver in a Tertiary Care Centre in Nepal
por: Bhattarai, Subash
Publicado: (2020)

Perceptions about the Management of Patients with DM2 and COVID-19 in the Hospital Care Setting
por: Gómez-Huelgas, Ricardo, et al.
Publicado: (2022)

Antioxidized LDL Antibodies Are Associated With Different Metabolic Pathways in Patients With Atherosclerotic Plaque and Type 2 Diabetes
por: Bernal-Lopez, M. Rosa, et al.
Publicado: (2013)

Telerehabilitation in patients with recent hospitalisation due to acute decompensated heart failure: protocol for the Tele-ADHF randomised controlled trial
por: van Leunen, Mayke M. C. J., et al.
Publicado: (2023)

Documentary Analysis of the Scientific Literature on Autism and Technology in Web of Science
por: Carmona-Serrano, Noemí, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qhuambrp76gr5mrv6851j6hn47